Indole derivatives as CRTH2 receptor antagonists
US8394819B2 · kind B2 · utility
4Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2010 |
| Grant date | Mar 12, 2013 |
| Priority date | — |
| Expiry date | Jan 22, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compound of formula I are antagonists of the PGD2 receptor, CRTH2, and as such are useful in the treatment and/or prevention of CRTH2-mediated diseases such as asthma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.